Drug Channels also had a big 2022. We now have 35,000 LinkedIn followers, almost 25,000 email subscribers, and nearly 16,000 Twitter followers.
Thank you, dear readers, for welcoming me into your inboxes and browsers each week. I’ve had a blast writing Drug Channels and hope that you had fun reading it.
Wishing you and your family health and happiness,
Ring in 2023 with our final news roundup of the year:
- A vertical integration update
- Walgreens backs away from prescriptions
- Meet a cash-pay pharmacy that’s not owned by a billionaire
- Time to cure or kill 340B?